Girao Tiago
Chief Financial Officer
Girao Tiago has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jul 24, 2026.
On the most recent filing, Girao Tiago is listed as Chief Financial Officer at Immunovant, Inc. Inside the rolling window, Girao Tiago reported no open-market purchases and 3 open-market sales totaling $1.4M in IMVT. The largest disclosed transaction in the window is a sale of 25,760 IMVT shares on Apr 23, 2026, worth $763K.
Companies traded
Other insiders at IMVT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Girao Tiago made?
Girao Tiago has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Girao Tiago trade?
Girao Tiago has filed SEC Form 4 disclosures for 1 company, including IMVT.
When was Girao Tiago's most recent SEC Form 4 filing?
Girao Tiago's most recent SEC Form 4 filing on Tracefour is dated Jul 24, 2026.
What is Girao Tiago's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Girao Tiago is listed as Chief Financial Officer.
What is Girao Tiago's total buy and sell value in the current window?
Inside the rolling retention window, Girao Tiago bought $0 and sold $1.4M based on SEC Form 4 filings.
What was Girao Tiago's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,760 IMVT shares on 2026-04-23, worth $763K, per SEC Form 4 filings.